Targeting CD36 With EP 80317 Reduces Remote Inflammatory Response to Hind Limb Ischemia‐Reperfusion in Mice
Hanan Elimam, Jade Gauvin, David N. Huynh, Liliane Ménard, Marie‐Lynn Al‐Hawat, Diala Harb, William D. Lubell, André C. Carpentier, Huy Ong, Sylvie Marleau · 2024
Read Targeting CD36 With EP 80317 Reduces Remote Inflammatory Response to Hind Limb Ischemia‐Reperfusion in Mice by Hanan Elimam, Jade Gauvin, David N. Huynh, Liliane Ménard, Marie‐Lynn Al‐Hawat, Diala Harb, William D. Lubell, André C. Carpentier, Huy Ong, Sylvie Marleau (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11582942.txt.
Description
Hanan Elimam and co-authors report a mouse study from 2024 on organ damage far from an injured leg muscle. When blood flow returns to muscle that has lost it, stress and swelling can also harm the lungs. The team asked if a drug that acts on a cell sensor called CD36 could calm that far-off harm.
Mice had one hind limb tied off for a short time, then blood flow was restored. The team measured stress signs, swelling signals, and gene activity in blood and lung tissue. The drug, named EP 80317, lowered pro-swelling signals in immune cells. The results suggest that blocking CD36 may limit lung injury after this kind of muscle harm.
Catalog record
| CREATOR | Hanan Elimam, Jade Gauvin, David N. Huynh, Liliane Ménard, Marie‐Lynn Al‐Hawat, Diala Harb, William D. Lubell, André C. Carpentier, Huy Ong, Sylvie Marleau |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |